Corporate News
Provided by:
Set Up E-mail Alerts For Corporate News »
Major corporate news developments tracked by the staff at StreetInsider.com
-
-
-
-
-
-
-
Regeneron (REGN) Reports Dupixent Recommended for EU Approval by the CHMP
-
-
-
-
-
-
-
Biogen (BIIB) Receives European Commission Approval for QALSODY, the First Therapy to Treat a Rare, Genetic Form of ALS
-
-
-
-
-
-
-
Dynex Capital (DX) Appoints Marie Chandoha to its Board
-
-
-
-
-
-
-
Lexington Realty Trust (LXP) Announces CFO Change
-
-
-
-
-
-
-
Collective Audience (CAUD) Receives Additional Nasdaq Non-compliance Notification
-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Files for 1.08M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Summit Therapeutics (SMMT): Ivonescimab Beats Pembrolizumab Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
-
324,371 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Corporate News reports.